HMI-202: Gene Therapy Development Candidate for Metachromatic Leukodystrophy (MLD) HMI-202: Gene Therapy Development Candidate for Metachromatic Leukodystrophy (MLD) Gingras J, St-Martin T, Gall K, et al. WORLDSymposium 2021.